Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblasts.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMC 3812518)

Published in World J Stem Cells on October 26, 2013

Authors

Maya Fakhry1, Eva Hamade, Bassam Badran, René Buchet, David Magne

Author Affiliations

1: Maya Fakhry, René Buchet, David Magne, ICBMS, UMR CNRS 5246, University of Lyon 1, 69622 Villeurbanne Cedex, France.

Articles citing this

Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells. Biomed Res Int (2015) 0.92

Potential mechanisms underlying the Runx2 induced osteogenesis of bone marrow mesenchymal stem cells. Am J Transl Res (2015) 0.90

The convergence of fracture repair and stem cells: interplay of genes, aging, environmental factors and disease. J Bone Miner Res (2014) 0.89

Should publications on mesenchymal stem/progenitor cells include in-process data on the preparation of the cells? Stem Cells Transl Med (2014) 0.85

Impact of tissue-specific stem cells on lineage-specific differentiation: a focus on the musculoskeletal system. Stem Cell Rev (2015) 0.83

Proteomics approaches for the studies of bone metabolism. BMB Rep (2014) 0.82

Biological strategies for improved osseointegration and osteoinduction of porous metal orthopedic implants. Tissue Eng Part B Rev (2014) 0.82

MiR-708 promotes steroid-induced osteonecrosis of femoral head, suppresses osteogenic differentiation by targeting SMAD3. Sci Rep (2016) 0.80

Mesenchymal stem cells in maxillary sinus augmentation: A systematic review with meta-analysis. World J Stem Cells (2015) 0.79

In vitro osteogenic and odontogenic differentiation of human dental pulp stem cells seeded on carboxymethyl cellulose-hydroxyapatite hybrid hydrogel. Front Physiol (2015) 0.78

Radiation-induced alterations of osteogenic and chondrogenic differentiation of human mesenchymal stem cells. PLoS One (2015) 0.77

Impact of electromagnetic fields on stem cells: common mechanisms at the crossroad between adult neurogenesis and osteogenesis. Front Cell Neurosci (2015) 0.77

INO80 is Required for Osteogenic Differentiation of Human Mesenchymal Stem Cells. Sci Rep (2016) 0.76

PARP Inhibitor PJ34 Suppresses Osteogenic Differentiation in Mouse Mesenchymal Stem Cells by Modulating BMP-2 Signaling Pathway. Int J Mol Sci (2015) 0.76

ARN: analysis and prediction by adipogenic professional database. BMC Syst Biol (2016) 0.75

ARN: Analysis and Visualization System for Adipogenic Regulation Network Information. Sci Rep (2016) 0.75

Mouse Mesenchymal Progenitor Cells Expressing Adipogenic and Osteogenic Transcription Factors Suppress the Macrophage Inflammatory Response. Stem Cells Int (2017) 0.75

Genomic analyses of early peri-implant bone healing in humans: a systematic review. Int J Implant Dent (2015) 0.75

Preferential Lineage-Specific Differentiation of Osteoblast-Derived Induced Pluripotent Stem Cells into Osteoprogenitors. Stem Cells Int (2017) 0.75

Rapid Rapamycin-Only Induced Osteogenic Differentiation of Blood-Derived Stem Cells and Their Adhesion to Natural and Artificial Scaffolds. Stem Cells Int (2017) 0.75

Articles cited by this

(truncated to the top 100)

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51

Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy (2006) 37.55

Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell (2002) 19.15

Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell (1997) 18.91

TGF-beta signal transduction. Annu Rev Biochem (1998) 17.83

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell (1997) 16.78

The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell (2002) 15.20

An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell (2003) 15.12

Identification of mammalian microRNA host genes and transcription units. Genome Res (2004) 14.63

Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell (1997) 13.53

Bone: formation by autoinduction. Science (1965) 13.34

Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A (2000) 11.41

Endocrine regulation of energy metabolism by the skeleton. Cell (2007) 10.41

Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell (2007) 10.13

Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med (1999) 9.73

Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development (2001) 9.00

Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell (2005) 8.16

Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell (1997) 7.47

MicroRNA function in animal development. FEBS Lett (2005) 6.93

Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell (2005) 6.90

Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells (2001) 6.86

Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A (2002) 6.05

TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science (2005) 5.56

A twist code determines the onset of osteoblast differentiation. Dev Cell (2004) 5.40

The amazing osteocyte. J Bone Miner Res (2011) 5.32

PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest (2004) 5.29

ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell (2004) 5.27

Why are MSCs therapeutic? New data: new insight. J Pathol (2009) 5.25

Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol (1966) 4.55

TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J (2000) 4.55

Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci U S A (2005) 4.48

Skeletal remodeling in health and disease. Nat Med (2007) 4.31

SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell (2006) 4.01

Retracted A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation. Nat Cell Biol (2007) 3.97

Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem (2005) 3.97

Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol (2000) 3.88

Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev (2003) 3.85

Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat Genet (1997) 3.70

Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis. Genes Dev (1995) 3.63

microRNAs and the immune response. Trends Immunol (2008) 3.63

Mesenchymal stromal cells: new directions. Cell Stem Cell (2012) 3.50

Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res (2006) 3.44

Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev (2005) 3.38

Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet (1997) 3.37

A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci U S A (2008) 3.29

MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells (2010) 3.16

A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J Clin Invest (2009) 3.03

Regulation of osteoblast differentiation by transcription factors. J Cell Biochem (2006) 2.86

Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem (2004) 2.71

Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma. J Biol Chem (2007) 2.69

Bone morphogenetic protein. J Dent Res (1972) 2.42

A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci U S A (2000) 2.31

CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. J Biol Chem (2001) 2.27

Bone tissue engineering: recent advances and challenges. Crit Rev Biomed Eng (2012) 2.27

Identification of SATB2 as the cleft palate gene on 2q32-q33. Hum Mol Genet (2003) 2.25

Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J Cell Biol (2001) 2.23

Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene. Gene (2006) 2.16

miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2. J Cell Biol (2012) 2.15

Patterns of expression of murine Vgr-1 and BMP-2a RNA suggest that transforming growth factor-beta-like genes coordinately regulate aspects of embryonic development. Genes Dev (1989) 2.10

A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2. Proc Natl Acad Sci U S A (2011) 2.05

miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. J Biol Chem (2010) 2.05

MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci U S A (2011) 2.05

The role of Dickkopf-1 in bone development, homeostasis, and disease. Blood (2008) 2.05

MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol (2012) 2.05

Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin. Mol Cell Biol (2006) 1.95

Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression. J Biol Chem (2005) 1.91

BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype. J Bone Miner Res (2006) 1.91

A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev (2009) 1.87

Wntless functions in mature osteoblasts to regulate bone mass. Proc Natl Acad Sci U S A (2012) 1.85

Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal. J Biol Chem (2008) 1.84

Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J Bone Miner Res (2003) 1.82

A microRNA regulatory mechanism of osteoblast differentiation. Proc Natl Acad Sci U S A (2009) 1.80

Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects. J Cell Biol (2004) 1.77

Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med (2008) 1.77

TAZ: a beta-catenin-like molecule that regulates mesenchymal stem cell differentiation. Cell Cycle (2006) 1.76

Activation of peroxisome proliferator-activated receptor-gamma inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts. J Biol Chem (2003) 1.76

Osteoinductive bone graft substitutes for lumbar fusion: a systematic review. J Neurosurg Spine (2009) 1.73

Short-term osteoclastic activity induced by locally high concentrations of recombinant human bone morphogenetic protein-2 in a cancellous bone environment. Spine (Phila Pa 1976) (2009) 1.71

Noncanonical Wnt-4 signaling enhances bone regeneration of mesenchymal stem cells in craniofacial defects through activation of p38 MAPK. J Biol Chem (2007) 1.70

miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells. Cell Death Differ (2010) 1.64

Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival. J Clin Invest (2011) 1.60

Bone morphogenetic protein (BMP) for fracture healing in adults. Cochrane Database Syst Rev (2010) 1.56

Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med (2008) 1.54

Overexpression of BMP-2 and BMP-4 alters the size and shape of developing skeletal elements in the chick limb. Mech Dev (1996) 1.54

Signaling networks in RUNX2-dependent bone development. J Cell Biochem (2011) 1.53

Cross-talk between Wnt signaling pathways in human mesenchymal stem cells leads to functional antagonism during osteogenic differentiation. J Cell Biochem (2007) 1.52

TWIST family of basic helix-loop-helix transcription factors mediate human mesenchymal stem cell growth and commitment. Stem Cells (2009) 1.47

The Fos-related antigen Fra-1 is an activator of bone matrix formation. EMBO J (2004) 1.46

Functional profiling reveals critical role for miRNA in differentiation of human mesenchymal stem cells. PLoS One (2009) 1.46

Canonical Wnts function as potent regulators of osteogenesis by human mesenchymal stem cells. J Cell Biol (2009) 1.44

Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem Biophys Res Commun (1996) 1.42

miR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells. J Biol Chem (2012) 1.39

Effects of protein dose and delivery system on BMP-mediated bone regeneration. Biomaterials (2011) 1.38

Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1. J Bone Miner Res (2011) 1.35

Gene transfer of the Runx2 transcription factor enhances osteogenic activity of bone marrow stromal cells in vitro and in vivo. Mol Ther (2005) 1.32

NF-kappaB activation stimulates osteogenic differentiation of mesenchymal stem cells derived from human adipose tissue by increasing TAZ expression. J Cell Physiol (2010) 1.31

A CCAAT/enhancer binding protein beta isoform, liver-enriched inhibitory protein, regulates commitment of osteoblasts and adipocytes. Mol Cell Biol (2005) 1.30

Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases. Mediators Inflamm (2013) 1.27

CCAAT/enhancer-binding protein beta promotes osteoblast differentiation by enhancing Runx2 activity with ATF4. Mol Biol Cell (2008) 1.27

Articles by these authors

Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur J Immunol (2009) 1.81

Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer. PLoS One (2011) 1.72

Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice. Cardiovasc Res (2005) 1.49

Proliferation and differentiation of human adipose-derived mesenchymal stem cells (ASCs) into osteoblastic lineage are passage dependent. Inflamm Res (2014) 1.41

Enhanced expression of the inorganic phosphate transporter Pit-1 is involved in BMP-2-induced matrix mineralization in osteoblast-like cells. J Bone Miner Res (2006) 1.33

The roles of annexins and alkaline phosphatase in mineralization process. Acta Biochim Pol (2003) 1.14

Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets. J Transl Med (2011) 1.13

Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia. J Transl Med (2013) 1.11

Lansoprazole is an uncompetitive inhibitor of tissue-nonspecific alkaline phosphatase. Acta Biochim Pol (2009) 1.09

Matrix vesicles originate from apical membrane microvilli of mineralizing osteoblast-like Saos-2 cells. J Cell Biochem (2009) 1.09

Bortezomib (PS-341, Velcade) increases the efficacy of trastuzumab (Herceptin) in HER-2-positive breast cancer cells in a synergistic manner. Mol Cancer Ther (2006) 1.07

Dexamethasone stimulates differentiation of odontoblast-like cells in human dental pulp cultures. Cell Tissue Res (2005) 1.06

VEGF and VEGF receptors are differentially expressed in chondrocytes. Bone (2006) 1.02

Proteomic characterization of biogenesis and functions of matrix vesicles released from mineralizing human osteoblast-like cells. J Proteomics (2011) 0.95

Phosphate-dependent regulation of MGP in osteoblasts: role of ERK1/2 and Fra-1. J Bone Miner Res (2009) 0.95

Vibrational spectroscopic detection of beta- and gamma-turns in synthetic and natural peptides and proteins. Chem Rev (2003) 0.95

MicroRNA profile of circulating CD4-positive regulatory T cells in human adults and impact of differentially expressed microRNAs on expression of two genes essential to their function. J Biol Chem (2012) 0.93

Multisystemic functions of alkaline phosphatases. Methods Mol Biol (2013) 0.91

Pre-interleukin-1alpha expression reduces cell growth and increases interleukin-6 production in SaOS-2 osteosarcoma cells: Differential inhibitory effect of interleukin-1 receptor antagonist (icIL-1Ra1). Cytokine (2005) 0.89

Cell-specific effects of TNF-α and IL-1β on alkaline phosphatase: implication for syndesmophyte formation and vascular calcification. Lab Invest (2011) 0.87

MyD88 in DNA repair and cancer cell resistance to genotoxic drugs. J Natl Cancer Inst (2013) 0.87

Valproate treatment of human cord blood CD4-positive effector T cells confers on them the molecular profile (microRNA signature and FOXP3 expression) of natural regulatory CD4-positive cells through inhibition of histone deacetylase. J Biol Chem (2010) 0.87

The active metabolite of leflunomide, A77 1726, increases the production of IL-1 receptor antagonist in human synovial fibroblasts and articular chondrocytes. Arthritis Res Ther (2004) 0.86

Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations. Int J Mol Sci (2013) 0.84

Phosphodiesterase activity of alkaline phosphatase in ATP-initiated Ca(2+) and phosphate deposition in isolated chicken matrix vesicles. J Biol Chem (2005) 0.84

Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts. Bone (2011) 0.84

Inhibitors of tissue-nonspecific alkaline phosphatase: design, synthesis, kinetics, biomineralization and cellular tests. Bioorg Med Chem (2013) 0.84

VIP differentially activates beta2 integrins, CR1, and matrix metalloproteinase-9 in human monocytes through cAMP/PKA, EPAC, and PI-3K signaling pathways via VIP receptor type 1 and FPRL1. J Leukoc Biol (2008) 0.84

Temperature dependence of ligand-protein complex formation as reflected by saturation transfer difference NMR experiments. Magn Reson Chem (2007) 0.81

Pertussis toxin activates adult and neonatal naive human CD4+ T lymphocytes. Eur J Immunol (2006) 0.81

Crosstalk between tyrosine kinase receptors, GSK3 and BMP2 signaling during osteoblastic differentiation of human mesenchymal stem cells. Mol Cell Endocrinol (2013) 0.81

Exposure of endothelial cells to physiological levels of myeloperoxidase-modified LDL delays pericellular fibrinolysis. PLoS One (2012) 0.81

Phosphate binding in the active site of alkaline phosphatase and the interactions of 2-nitrosoacetophenone with alkaline phosphatase-induced small structural changes. Biophys J (2004) 0.80

Macrophage and osteoblast responses to biphasic calcium phosphate microparticles. J Biomed Mater Res A (2010) 0.80

Secondary structure analysis of HIV-1-gp41 in solution and adsorbed to aluminum hydroxide by Fourier transform infrared spectroscopy. Biochim Biophys Acta (2007) 0.80

Structure-function relations in oxaloacetate decarboxylase complex. Fluorescence and infrared approaches to monitor oxomalonate and Na(+) binding effect. PLoS One (2010) 0.80

Mitochondrial creatine kinase binding to phospholipid monolayers induces cardiolipin segregation. Biophys J (2009) 0.79

The neuropeptide pituitary adenylate cyclase activating polypeptide modulates Ca2+ and pro-inflammatory functions in human monocytes through the G protein-coupled receptors VPAC-1 and formyl peptide receptor-like 1. Cell Calcium (2007) 0.79

Progressive loss of CD3 expression after HTLV-I infection results from chromatin remodeling affecting all the CD3 genes and persists despite early viral genes silencing. Virol J (2007) 0.79

Isolation and characteristics of matrix vesicles. Methods Mol Biol (2013) 0.78

Dendritic cells generated in clinical grade bags strongly differ in immune functionality when compared with classical DCs generated in plates. J Immunother (2010) 0.78

Dimethyl sulfoxide-induced hydroxyapatite formation: a biological model of matrix vesicle nucleation to screen inhibitors of mineralization. Anal Biochem (2008) 0.77

A hydrophobic disordered peptide spontaneously anchors a covalently bound RNA hairpin to giant lipidic vesicles. Org Biomol Chem (2014) 0.77

Synthesis and evaluation of thiophenyl derivatives as inhibitors of alkaline phosphatase. Bioorg Med Chem Lett (2011) 0.77

Interleukin-33: a novel player in osteonecrosis of the femoral head? Joint Bone Spine (2011) 0.77

Direct determination of phospholipase D activity by infrared spectroscopy. Anal Biochem (2012) 0.77

A putative consensus sequence for the nucleotide-binding site of annexin A6. Biochemistry (2003) 0.77

Conformational and interfacial analyses of K3A18K3 and alamethicin in model membranes. J Phys Chem B (2009) 0.76

Mg-nucleotides induced dissociation of liposome-bound creatine kinase: reversible changes in its secondary structure and in the fluidity of the bilayer. Mol Membr Biol (2003) 0.76

Synthesis and evaluation of benzo[b]thiophene derivatives as inhibitors of alkaline phosphatases. Bioorg Med Chem (2009) 0.76

Traumatic Brain Injury and Blood-Brain Barrier Cross-Talk. CNS Neurol Disord Drug Targets (2016) 0.76

Acyl chain composition determines cardiolipin clustering induced by mitochondrial creatine kinase binding to monolayers. Biochim Biophys Acta (2011) 0.76

New analogues of 13-hydroxyocatdecadienoic acid and 12-hydroxyeicosatetraenoic acid block human blood platelet aggregation and cyclooxygenase-1 activity. Chem Cent J (2012) 0.75

Role of nitric oxide and CCAAT/enhancer-binding protein transcription factor in statin-dependent induction of heme oxygenase-1 in mouse macrophages. PLoS One (2013) 0.75

Chick embryo anchored alkaline phosphatase and mineralization process in vitro. Eur J Biochem (2003) 0.75

Distinct structure and activity recoveries reveal differences in metal binding between mammalian and Escherichia coli alkaline phosphatases. Biochem J (2005) 0.75

Chemical composition and antioxidant activity of a Lebanese plant Euphorbia macroclada schyzoceras. Asian Pac J Trop Biomed (2013) 0.75

[Kinetic study on inhibition effects of dansyl-L-phenylalanine and L-phenylalanine on calf intestinal alkaline phosphatase]. Guang Pu Xue Yu Guang Pu Fen Xi (2009) 0.75

beta-TCP microporosity decreases the viability and osteoblast differentiation of human bone marrow stromal cells. J Biomed Mater Res A (2008) 0.75

Correction: Valproate treatment of human cord blood CD4-positive effector T cells confers on them the molecular profile (microRNA signature and FOXP3 expression) of natural regulatory CD4-positive cells through inhibition of histone deacetylase. J Biol Chem (2011) 0.75

Chemical composition, in vitro cytotoxicity and anti-free radical properties of six extracts from Lebanese Trigonella berythea Boiss. Pak J Pharm Sci (2013) 0.75

Apolipoprotein L Expression Correlates with Neutrophil Cell Death in Critically Ill Patients. Shock (2017) 0.75

Deregulation of calcium fluxes in HTLV-I infected CD4-positive T-cells plays a major role in malignant transformation. Front Biosci (Landmark Ed) (2009) 0.75

Characterization of caged compounds binding to proteins by NMR spectroscopy. Biochem Biophys Res Commun (2010) 0.75

Distinct actions of strontium on mineral formation in matrix vesicles. Biochem Biophys Res Commun (2008) 0.75

Sinomenine, theophylline, cysteine, and levamisole: Comparisons of their kinetic effects on mineral formation induced by matrix vesicles. J Inorg Biochem (2010) 0.75